Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.
about
Estrogen-cholinergic interactions: Implications for cognitive agingBiomarkers of postoperative delirium and cognitive dysfunctionStimulation of M3 muscarinic receptors induces phosphorylation of the Cdc42 effector activated Cdc42Hs-associated kinase-1 via a Fyn tyrosine kinase signaling pathwayCholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseasePreclinical testing of N-[(11)c]-methyl-piperidin-4-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, a novel radioligand for detection of cerebral muscarinic receptors using PETA predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systemsAltered extracellular signal-regulated kinase signal transduction by the muscarinic acetylcholine and metabotropic glutamate receptors after cerebral ischemiaAllosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys.Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.Proteomic analysis for protein carbonyl as an indicator of oxidative damage in senescence-accelerated mice.GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability.Molecules of the brain.Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulatorsMolecular ontogeny of major neurotransmitter receptor systems in the mammalian central nervous system: norepinephrine, dopamine, serotonin, acetylcholine, and glycine.GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity.Lesions of the basal forebrain cholinergic system in mice disrupt idiothetic navigation.Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs.The role of acetylcholine in cocaine addiction.Deer bone extract prevents against scopolamine-induced memory impairment in miceDisturbed neurotransmitter transporter expression in Alzheimer's disease brainTong Luo Jiu Nao ameliorates Aβ1-40-induced cognitive impairment on adaptive behavior learning by modulating ERK/CaMKII/CREB signaling in the hippocampus.Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathwayTransmitter receptors and functional anatomy of the cerebral cortex.Memory: recording experience in cells and circuits: diversity in memory researchThe keystone of Alzheimer pathogenesis might be sought in Aβ physiologyThe anterior cingulate cortex may enhance inhibition of lateral prefrontal cortex via m2 cholinergic receptors at dual synaptic sites.Protection Efficacy of the Extract of Ginkgo biloba against the Learning and Memory Damage of Rats under Repeated High Sustained +Gz Exposure.Comparative study of korean white, red, and black ginseng extract on cholinesterase inhibitory activity and cholinergic functionAmyloid-β peptide: Dr. Jekyll or Mr. Hyde?Catalpol Induces Neuroprotection and Prevents Memory Dysfunction through the Cholinergic System and BDNF.GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2/M4 autoreceptor desensitization.Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.M1 muscarinic acetylcholine receptor in Alzheimer's diseasePharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.Cholinergic modulation of the hippocampal region and memory function.Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284.
P2860
Q26799402-E1F47C34-4446-47CC-84D3-63E1741CDC80Q26830796-E112E0CC-B5CE-477C-BFA8-DC584ECFBF16Q28138302-14CD3CF0-CCA3-4D17-BC3F-181D036E7D51Q28287090-8CB44E07-24C2-4EA6-A2A3-01CD1D91FE33Q28377156-39C29F00-CD08-4077-8CEE-3DAF7928D901Q28543817-7F00E096-CD39-445A-A004-F0F4D72ADFB0Q28565587-F7CECC09-9758-4F23-A2AC-2B3715CD9E62Q30388923-923A437C-894B-4494-ABBA-6F0360F16EF6Q30446914-137FB57A-8CEE-4800-A7B8-AE9005700CC4Q30453015-DCD4CB06-430F-4A0B-980C-6A93AE8D7917Q30457688-2DF1EF57-DE2E-4015-9E86-425EA5DDE156Q30489795-0363EF8F-503E-4DC0-8DBA-8602A3944CB9Q33260812-6B59C65E-7247-4B55-B032-F35F6863AE2FQ33363144-23E8CBE0-7576-45F5-9FCD-EB589D8B2415Q33846594-63D95D9C-D3F6-462C-AC38-5C79592C87E4Q34184921-0A8AAE65-DE02-428C-8EAB-F7FB65F462E7Q34238346-85802C98-EC63-4531-A778-18F92C7B11BAQ34438832-E5735363-6825-43B8-80D8-F74E6771938AQ34548261-09613522-2C7D-4EAF-9D40-43E004A05DB6Q34558128-91CB2E29-87D2-4544-B1F0-7F325E4B6548Q34700186-72066A4D-9755-4470-BBDE-5EB8FEA9DFB2Q35034661-C9BD211E-7C94-4999-A4F3-67A344C20CBFQ35285149-0124A1BD-09C3-47E9-B260-317677A8DC9EQ35608188-BDD85E78-B73C-4BB1-BFBC-5A37D7D0976EQ35944934-0120FE5F-6E99-40F6-99B4-EEBB6B2C8C95Q35989555-ECE399EC-144F-4171-999D-BD5244E565B1Q35996151-7C7AA0A2-C238-4314-BDE6-478E9E5349C8Q36113757-3D0BDC31-15E3-4C4C-8928-F7DC7438547BQ36469220-585DE83F-9EBA-42F3-A7FD-6801DA95165FQ36741440-7E677C0F-0B56-430E-BECC-5FE235661D7BQ36860984-F3193883-6621-4691-A9AB-DBA3B155A4C1Q36966660-2EF29180-E3A8-4B36-B0FA-D76D45B35514Q37195211-0363F9D3-6008-4D4B-8912-932EE7A8F518Q37339351-1CBD234B-417E-4B14-AA66-F5F6CC236972Q37977251-CAC458F9-0EF3-4FF4-B1A6-BE948361493AQ38099889-57BF76AF-81EA-4547-9E87-7D918F5B1B88Q38192962-D2792E77-C434-4D93-8259-03ADC0260E2DQ38208461-07A6F94D-EF74-4AE9-87DC-A7874A562A9EQ38372480-7ADD0E00-D656-437A-AB17-32F659E8A24BQ38759673-65FC5900-557B-47E8-A8A3-D2E733D74EEC
P2860
Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@ast
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@en
type
label
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@ast
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@en
prefLabel
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@ast
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@en
P2860
P356
P1476
Muscarinic acetylcholine recep ...... reatment of Alzheimer disease.
@en
P2093
P2860
P304
13541-13546
P356
10.1073/PNAS.93.24.13541
P407
P577
1996-11-01T00:00:00Z